The global market for Pharmacovigilance and Drug Safety Software was estimated at US$216.1 Million in 2023, and is projected to reach US$321.1 Million by 2030, growing at a CAGR of 5.8% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. ![Global Pharmacovigilance and Drug Safety Software Market]( "Global Pharmacovigilance and Drug Safety Software Market")
Key Insights:
- Market Growth: Understand the significant growth trajectory of the ADR Reporting Functionality segment, which is expected to reach US$146.0 Million by 2030 with a CAGR of a 5.4%. The Drug Safety Audits Functionality segment is also set to grow at 6.1% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $58.3 Million in 2023, and China, forecasted to grow at an impressive 5.5% CAGR to reach $50.5 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Pharmacovigilance and Drug Safety Software Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Pharmacovigilance and Drug Safety Software Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Pharmacovigilance and Drug Safety Software Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as AB Cube, ArisGlobal LLC, Ennov USA, and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 47 Featured):
- AB Cube
- ArisGlobal LLC
- Ennov USA
- Extedo GmbH
- Online Business Applications, Inc.
- Oracle Corporation
- Sarjen Systems Pvt. Ltd.
- Sparta Systems, Inc.
- United Biosource Corporation
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISIV. COMPETITION
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Pharmacovigilance and Drug Safety Software - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
- Global Economic Update
3. MARKET TRENDS & DRIVERS
- Increasing Regulatory Requirements for Drug Safety and Monitoring
- Advances in AI and Machine Learning Enhance Pharmacovigilance Capabilities
- Growth in Pharmaceutical Industry Drives Demand for Drug Safety Solutions
- Rising Focus on Patient Safety and Adverse Event Reporting
- Expansion of Global Pharmacovigilance Network
- Increasing Complexity of Drug Development and Safety Monitoring
- Technological Advancements in Data Analytics and Big Data
- Demand for Cloud-Based Pharmacovigilance Solutions
- Rising Investment in Healthcare IT Infrastructure
- Development of Integrated Pharmacovigilance Systems
- Increasing Use of Real-World Data and Evidence
- Adoption of Automation and Robotics in Drug Safety Processes
- Expansion of Clinical Trials and Post-Marketing Surveillance
4. GLOBAL MARKET PERSPECTIVE
- Table 1: World Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
- Table 2: World 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
- Table 3: World Recent Past, Current & Future Analysis for ADR Reporting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
- Table 4: World 7-Year Perspective for ADR Reporting by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
- Table 5: World Recent Past, Current & Future Analysis for Drug Safety Audits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
- Table 6: World 7-Year Perspective for Drug Safety Audits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
- Table 7: World Recent Past, Current & Future Analysis for Issue Tracking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
- Table 8: World 7-Year Perspective for Issue Tracking by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
- Table 9: World Recent Past, Current & Future Analysis for Fully Integrated Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
- Table 10: World 7-Year Perspective for Fully Integrated Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
- Table 11: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
- Table 12: World 7-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
- Table 13: World Recent Past, Current & Future Analysis for BPOs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
- Table 14: World 7-Year Perspective for BPOs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
- Table 15: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
- Table 16: World 7-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
- Table 17: World Pharmacovigilance and Drug Safety Software Market Analysis of Annual Sales in US$ for Years 2014 through 2030
- Table 18: World Recent Past, Current & Future Analysis for On-Premise by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
- Table 19: World 7-Year Perspective for On-Premise by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
- Table 20: World Recent Past, Current & Future Analysis for Cloud by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
- Table 21: World 7-Year Perspective for Cloud by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
- Table 22: World Recent Past, Current & Future Analysis for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
- Table 23: World 7-Year Perspective for Contract Research Organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
UNITED STATES
- Pharmacovigilance and Drug Safety Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
- Table 24: USA Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Functionality - ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 25: USA 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Functionality - Percentage Breakdown of Value Sales for ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software for the Years 2024 & 2030
- Table 26: USA Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by End-Use - Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 27: USA 7-Year Perspective for Pharmacovigilance and Drug Safety Software by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses for the Years 2024 & 2030
- Table 28: USA Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 29: USA 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
CANADA
- Table 30: Canada Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Functionality - ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 31: Canada 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Functionality - Percentage Breakdown of Value Sales for ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software for the Years 2024 & 2030
- Table 32: Canada Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by End-Use - Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 33: Canada 7-Year Perspective for Pharmacovigilance and Drug Safety Software by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses for the Years 2024 & 2030
- Table 34: Canada Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 35: Canada 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
JAPAN
- Pharmacovigilance and Drug Safety Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
- Table 36: Japan Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Functionality - ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 37: Japan 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Functionality - Percentage Breakdown of Value Sales for ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software for the Years 2024 & 2030
- Table 38: Japan Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by End-Use - Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 39: Japan 7-Year Perspective for Pharmacovigilance and Drug Safety Software by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses for the Years 2024 & 2030
- Table 40: Japan Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 41: Japan 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
CHINA
- Pharmacovigilance and Drug Safety Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
- Table 42: China Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Functionality - ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 43: China 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Functionality - Percentage Breakdown of Value Sales for ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software for the Years 2024 & 2030
- Table 44: China Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by End-Use - Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 45: China 7-Year Perspective for Pharmacovigilance and Drug Safety Software by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses for the Years 2024 & 2030
- Table 46: China Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 47: China 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
EUROPE
- Pharmacovigilance and Drug Safety Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
- Table 48: Europe Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
- Table 49: Europe 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
- Table 50: Europe Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Functionality - ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 51: Europe 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Functionality - Percentage Breakdown of Value Sales for ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software for the Years 2024 & 2030
- Table 52: Europe Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by End-Use - Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 53: Europe 7-Year Perspective for Pharmacovigilance and Drug Safety Software by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses for the Years 2024 & 2030
- Table 54: Europe Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 55: Europe 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
FRANCE
- Pharmacovigilance and Drug Safety Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
- Table 56: France Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Functionality - ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 57: France 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Functionality - Percentage Breakdown of Value Sales for ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software for the Years 2024 & 2030
- Table 58: France Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by End-Use - Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 59: France 7-Year Perspective for Pharmacovigilance and Drug Safety Software by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses for the Years 2024 & 2030
- Table 60: France Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 61: France 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
GERMANY
- Pharmacovigilance and Drug Safety Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
- Table 62: Germany Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Functionality - ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 63: Germany 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Functionality - Percentage Breakdown of Value Sales for ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software for the Years 2024 & 2030
- Table 64: Germany Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by End-Use - Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 65: Germany 7-Year Perspective for Pharmacovigilance and Drug Safety Software by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses for the Years 2024 & 2030
- Table 66: Germany Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 67: Germany 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
ITALY
- Table 68: Italy Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Functionality - ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 69: Italy 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Functionality - Percentage Breakdown of Value Sales for ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software for the Years 2024 & 2030
- Table 70: Italy Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by End-Use - Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 71: Italy 7-Year Perspective for Pharmacovigilance and Drug Safety Software by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses for the Years 2024 & 2030
- Table 72: Italy Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 73: Italy 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
UNITED KINGDOM
- Pharmacovigilance and Drug Safety Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
- Table 74: UK Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Functionality - ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 75: UK 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Functionality - Percentage Breakdown of Value Sales for ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software for the Years 2024 & 2030
- Table 76: UK Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by End-Use - Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 77: UK 7-Year Perspective for Pharmacovigilance and Drug Safety Software by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses for the Years 2024 & 2030
- Table 78: UK Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 79: UK 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
REST OF EUROPE
- Table 80: Rest of Europe Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Functionality - ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 81: Rest of Europe 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Functionality - Percentage Breakdown of Value Sales for ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software for the Years 2024 & 2030
- Table 82: Rest of Europe Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by End-Use - Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 83: Rest of Europe 7-Year Perspective for Pharmacovigilance and Drug Safety Software by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses for the Years 2024 & 2030
- Table 84: Rest of Europe Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 85: Rest of Europe 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
ASIA-PACIFIC
- Pharmacovigilance and Drug Safety Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
- Table 86: Asia-Pacific Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Functionality - ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 87: Asia-Pacific 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Functionality - Percentage Breakdown of Value Sales for ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software for the Years 2024 & 2030
- Table 88: Asia-Pacific Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by End-Use - Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 89: Asia-Pacific 7-Year Perspective for Pharmacovigilance and Drug Safety Software by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses for the Years 2024 & 2030
- Table 90: Asia-Pacific Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 91: Asia-Pacific 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
REST OF WORLD
- Table 92: Rest of World Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Functionality - ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 93: Rest of World 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Functionality - Percentage Breakdown of Value Sales for ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software for the Years 2024 & 2030
- Table 94: Rest of World Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by End-Use - Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 95: Rest of World 7-Year Perspective for Pharmacovigilance and Drug Safety Software by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses for the Years 2024 & 2030
- Table 96: Rest of World Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- Table 97: Rest of World 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
Companies Mentioned
- AB Cube
- ArisGlobal LLC
- Ennov USA
- Extedo GmbH
- Online Business Applications, Inc.
- Oracle Corporation
- Sarjen Systems Pvt. Ltd.
- Sparta Systems, Inc.
- United Biosource Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 181 |
| Published | November 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 216.1 Million |
| Forecasted Market Value ( USD | $ 321.1 Million |
| Compound Annual Growth Rate | 5.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 9 |
